Loading...
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer.
Meyer, T Caplin, M E Palmer, D H Valle, Juan W Larvin, M Waters, J S Coxon, F Borbath, I Peeters, M Nagano, E
Meyer, T
Caplin, M E
Palmer, D H
Valle, Juan W
Larvin, M
Waters, J S
Coxon, F
Borbath, I
Peeters, M
Nagano, E
Citations
Altmetric:
Abstract
To evaluate the combination of the gastrin antagonist Z-360 and gemcitabine for advanced pancreatic cancer.
Affiliation
Description
Date
2010-02
Publisher
Collections
Keywords
Type
Article
Citation
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer. 2010, 46 (3):526-33 Eur J Cancer